Found 5 matching trials
Study of Coagulation Faction VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia
PHASE1This multi-center, open label Phase 1 study will evaluate the pharmacokinet...
Location
Medical Center "Hippocrates - N"
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Hemophilia A or B
PHASE3The purpose of the trial is to evaluate the safety and efficacy of MarzAA f...
Location
Phoenix Children's Hospital
Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
PHASE2Phase 2, multi-center, open-label study designed to evaluate the PK, bioava...
Location
Hematology Center after Prof. R. Yeolyan
Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia
PHASE1This study hypothesizes that the study drug, PF-05280602 (at the selected d...
Location
University of California San Diego Medical Center
Study of Coagulation Factor VIIa Marzeptacog Alfa (Activated) in Subjects With Inherited Bleeding Disorders
PHASE1The purpose of the trial is to evaluate the PK, bioavailability, PD, effica...
Location
UC Davis Medical Center